Carton Label (Carton)
Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 51817-586
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 51817-586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmascience Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bortezomib Chemical Structure (Chemical Structure)
Graph (Time to progression)
Graph (Overall survival)
Graph (Time to progression)
This is a graph displaying the proportion of patients who received Bortezomib over time (in days) compared to the proportion of patients who received Doxamethasone. The p-value from the log-rank test is less than 0.00017, indicating a statistically significant difference between the two groups. The number of patients remaining at each time point is also given.*
Graph (Overall survival)
This text represents the proportion of patients receiving Bortezomib and Dexamethasone at different time points. There is a statistical significance between the two treatments represented by a p-value obtained through a log-rank test. However, further information is not available to provide more context.*
Progression Free Survival (Figure5)
This appears to be a table representing different subjects and their performance over time. The subjects are labeled as "VeR-CAP" and "RCHOP" and the performance is measured based on the month. The table seems to have columns displaying the months and percentage values. A detailed analysis is difficult without a better understanding of the source material.*
Overall Survival (Figure6)
This is a graph that shows the survival rate of subjects enrolled in a clinical trial for two treatments named VGR-CAP and R-CHOP. The Hazard Ratio value is also provided. It is not possible to determine the type of clinical trial, medical condition or treatment details as the text contains limited information.*
Vial Label (Vial)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
